Dr.Hong Lin is a lecturer of Ningxia Medical University. She has been honored with the titles of "Young Model Worker in the Regional Health System" and "Advanced Individual" as well as other awards. She is a member of the Elderly Health and Integrated Medical-Nursing Care Working Committee, Chinese Preventive Medicine Association, and the Health Management Professional Committee of Ningxia Nursing Association. She has long been engaged in studying the mechanisms of chronic disease prevention and control measures in order to mitigate the impact of chronic diseases. Dr. Lin has published over ten academic papers, and has independently undertaken or participated in more than 5 research projects funded by funds at home and abroad. She has been an editorial member of "Modern Nurse".

Chronic Disease Prevention and Management Research in Populations

2021– 2024   Ningxia Medical University, Yinchuan, China,Ph.D. in Epidemiology and Health tatistics

2013– 2016   Ningxia Medical University, Yinchuan, China,M.S. in Epidemiology and Health Statistics

2008– 2013   Ningxia Medical University, Yinchuan, China,B.M. in Epidemiology and Health Statistics

2025     High-level Talent in Ningxia Hui Autonomous Region 

             Ningxia Hui Human Resources and Social Security Department

2023     Doctoral Second-Class Scholarship

             Ningxia Medical University

2022     Doctoral First-Class Scholarship

             Ningxia Medical University

2021     Doctoral Second-Class Scholarship

             Ningxia Medical University

2020     Role Model in the Fight Against the Epidemic Around Me( The 4th Issue )

             Ningxia Hui Autonomous Region Health Commission

2020     Outstanding Individual Award

             Shizuishan Center For Disease Control and Prevention

2018     Youth Model Worker of the Regional Health System

             Ningxia Hui Autonomous Region Health Commission

2018     Outstanding Individual Award

             Shizuishan Center For Disease Control and Prevention

2012     Undergraduate Third-Class Scholarship

             Ningxia Medical University

2010     Undergraduate Second-Class Scholarship

             Ningxia Medical University

08/2025 – Presen   Exploring the Mechanism of Alistipes shahii in Ameli  orating MASH Lipid Metabolism Disorders Through the Gut Microbiota-SCFAs-GPR43 Axis and IL-6/JAK/STAT3 Signaling Pathway. Project funded by the Natural Science Foundation. Role: Co-Principal Investigator. RMB 320,000.

06/2025 – Present   Exploring the Mechanism of Lycium Barbarum Polysaccharide in Ameliorating NAFLD Lipid Deposition Through the IDO1-Kyn-AHR Signaling Axis. Project funded by the Natural Science Foundation of Ningxia Hui Autonomous Region. Role: Principal Investigator. RMB 80,000.

10/2024 – Present   Machine Learning-Based Study on Cardiovascular-Metabolic Multimorbidity Networks and System Dynamics Models in the Elderly of Ningxia. Project funded by the Natural Science Foundation of Ningxia Hui Autonomous Region. Role: Co-Principal Investigator. RMB 80,000.

01/2023 – Present   Machine Learning-Based Study on Cardiovascular-Metabolic Multimorbidity Networks and System Dynamics Models in the Elderly of Ningxia. Project funded by the Natural Science Foundation of Ningxia Hui Autonomous Region. Role: Co-Principal Investigator. RMB 80,000.

9/2020 – 9/2023   Influenza immunogenicity and vaccine uptake determinants across age groups in Shizuishan, China. Project funded by the the Ningxia Hui Autonomous Region Health Commission. Role: Principal Investigator. RMB 8000.

1. Mou, J., Yang, J., Sun, Y., Liu, J., Zhao, Y., Lin, H., & Yang, J. (2025). An arabinogalactan from Lycium barbarum mitigated DSS caused intestinal injury via inhibiting mucosal damage and regulating the gut microbiota disorder. Carbohydr Polym. 2025 Mar 15;352:123155.

2. Gong, W., Hu, X., Cui, H., Zhao, Y., Lin, H., Sun, P., & Yang, J. (2025). Socioeconomic status and lifestyle as factors of multimorbidity among older adults in China: results from the China Health and Retirement Longitudinal Survey. Frontiers in public health, 13, 1586091.

3. Zhao, Y., Cui, H., Lin, H., Gong, W., Li, N., & Yang, J. (2025). Angiotensin-Converting Enzyme Inhibitory Peptide Derived from Ultrafine Lycium barbarum Pomace Powder: In Vitro and In Silico Analysis. Journal of agricultural and food chemistry, 73(32), 20149–20162.

4. Lin, H., Gong, W., Zhao, Y., & Yang, J. (2024). Dietary intervention with Lycium barbarum polysaccharide and quinoa ultrafine powder ameliorates lipid metabolism in nonalcoholic fatty liver disease by regulating gut microbiota and activating AMPK/SREBP-1C/SCD-1 signaling. Food Science and Human Wellness. Advance online publication. https://doi.org/10.26599/FSHW.2024.9250427.

5. Gong, W., Lin, H., Ma, X., & Yang, J. (2024). The regional disparities in liver disease comorbidity among elderly Chinese based on a health ecological model: The China Health and Retirement Longitudinal Study. BMC Public Health, 24(1), 1123.